• Tel:+86 16600087706
  • Tel:010-88814240
  • Email:sales01@yibaibiotech.com
    • dsdsa

    product

    2020 Good Quality Daclatasvir - Pharmaceutical Grade 1256388-51-8 Ledipasvir For Treatment of Hepatitis C – Yibai Featured Image
    • 2020 Good Quality Daclatasvir - Pharmaceutical Grade 1256388-51-8 Ledipasvir For Treatment of Hepatitis C – Yibai
    • 2020 Good Quality Daclatasvir - Pharmaceutical Grade 1256388-51-8 Ledipasvir For Treatment of Hepatitis C – Yibai
    • 2020 Good Quality Daclatasvir - Pharmaceutical Grade 1256388-51-8 Ledipasvir For Treatment of Hepatitis C – Yibai

    2020 Good Quality Daclatasvir - Pharmaceutical Grade 1256388-51-8 Ledipasvir For Treatment of Hepatitis C – Yibai

    Short Description:


    Download as PDF

    Product Detail

    FAQ

    Product Tags

    Related Video

    Feedback (2)

    owing to excellent assistance, a variety of high quality products and solutions, aggressive costs and efficient delivery, we take pleasure in an excellent popularity amongst our customers. We are an energetic business with wide market for 65-19-0, Paclitaxel Powder, Enzalutamide, All products come with good quality and perfect after-sales services. Market-oriented and customer-oriented are what we have been being after. Sincerely look forward to Win-Win cooperation !
    2020 Good Quality Daclatasvir - Pharmaceutical Grade 1256388-51-8 Ledipasvir For Treatment of Hepatitis C – Yibai Detail:

    Product name Ledipasvir
    Synonyms Ledipasvir compd. with acetone
    CAS No. 1256388-51-8
    Appearance Off-white powder
    Molecular Formula C49H54F2N8O6
    Molecular Weight 889.00
    Usage Pharmaceutical Grade or Research purpose
    Packing As per your request
    Storage Preserve in tight,light-resistant containers in a cool place

     

    Ledipasvir Cas: 1441674-54-9

    Items

    Standard

    Results

    Appearance

    		 Off-white powder Off-white powder

    Identification

    		 Sample and standard exhibit the sameretention time Complies

    Water

    		 NMT 1.0% 0.20%

    Enantiomer

    		 NMT 1.0% ND

    Related substance

    		 Total impurities NMT 1.0% 0.52%

    Purity

    		 ≥99.0% 99.48%
    Conclusion: complies with the in-house standards.

    Company Information

    √ Management layer’s full experience in factory and skilled technicians followers;
    √ Quality is always our top consideration, Strict QC system;
    √ 11 years experienced exporting sales team;
    √ Independent R&D lab;
    √ Two signed long term GMP workshops;
    √ Rich resources of plenty idle factories for customized project;
    √ High Efficiency working team with consistent path.
    imgsafSDGSHDASFG
    Product detail pictures:

    2020 Good Quality Daclatasvir - Pharmaceutical Grade 1256388-51-8 Ledipasvir For Treatment of Hepatitis C – Yibai detail pictures

    2020 Good Quality Daclatasvir - Pharmaceutical Grade 1256388-51-8 Ledipasvir For Treatment of Hepatitis C – Yibai detail pictures

    2020 Good Quality Daclatasvir - Pharmaceutical Grade 1256388-51-8 Ledipasvir For Treatment of Hepatitis C – Yibai detail pictures

    Related Product Guide:
    We thinks what buyers think, the urgency of urgency to act during the interests of a purchaser position of theory, allowing for much better high-quality, reduced processing costs, charges are more reasonable, won the new and outdated consumers the support and affirmation for 2020 Good Quality Daclatasvir - Pharmaceutical Grade 1256388-51-8 Ledipasvir For Treatment of Hepatitis C – Yibai , The product will supply to all over the world, such as: Luxembourg, Canada, Finland, We insist on the principle of "Credit being primary, Customers being the king and Quality being the best", we are looking forward to the mutual cooperation with all friends at home and abroad and we will create a bright future of business.
    • Company director has very rich management experience and strict attitude, sales staff are warm and cheerful, technical staff are professional and responsible,so we have no worry about product,a nice manufacturer.
    5 Stars By Marco from Bulgaria - 2017.03.28 12:22
    The accounts manager made a detailed introduction about the product, so that we have a comprehensive understanding of the product, and ultimately we decided to cooperate.
    5 Stars By May from Saudi Arabia - 2018.12.11 11:26
    Write your message here and send it to us

    related products